IP Verse

Advanz Pharma Services Uk competitive analysis

Latest oppositions filed by Advanz Pharma Services Uk

Explore patent oppositions filed by Advanz Pharma Services Uk against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
EP4364724
High Concentration Vegf Receptor Fusion Protein Containing FormulationsREGENERON PHARMACEUTICALSAug 21, 2026
EP4185318
Extended, High Dose Vegf Antagonist Regimens For Treatment Of Angiogenic Eye DisordersBAYER HEALTHCAREJun 1, 2026
EP3329965
Dosing Regimen Of Anti-Alpha4Beta7-AntibodiesMILLENNIUM PHARMACEUTICALSDec 18, 2025
EP3744326
Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICASep 6, 2024
EP2234617
Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICADec 3, 2021

Latest PTAB cases involving Advanz Pharma Services Uk

Discover the latest PTAB cases involving Advanz Pharma Services Uk, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Advanz Pharma Services Uk with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ADVANZ PHARMA SERVICES UK5 - - -
BAYER HEALTHCARE - 22 - 1
MILLENNIUM PHARMACEUTICALS - 11 - -
REGENERON PHARMACEUTICALS39141932